MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
Mari YoshiokaJanuary 5, 2022
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Sonde Health Partners with GN Group to Research and Develop New Vocal Biomarker Technology to Detect Mild Cognitive Impairment

Mari YoshiokaJanuary 18, 2022
Next

Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine through its Pipeline of RNA Editing Programs

Mari YoshiokaJanuary 5, 2022

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact